Chronic stress reshapes brain and behavior in ways that increase vulnerability to substance use disorders. Biological stress responses normally mobilize resources through the HPA axis and the autonomic nervous system, but repeated activation produces allostatic load, a cumulative wear-and-tear on neural systems described by Bruce McEwen at Rockefeller University. Over time this load alters stress signaling molecules such as corticotropin-releasing factor and cortisol, and changes the balance of neurotransmitters that regulate mood, reward, and impulse control.
Biological mechanisms
Research by Nora Volkow at the National Institute on Drug Abuse shows that chronic stress alters reward circuitry, including dopamine pathways in the nucleus accumbens and prefrontal cortical regulation. These changes reduce sensitivity to natural rewards, making drugs that strongly activate dopamine more reinforcing. George Koob at the National Institute on Alcohol Abuse and Alcoholism and colleagues have emphasized how stress-related neuroadaptations in the extended amygdala increase negative emotional states that drive drug-seeking through negative reinforcement—using substances to relieve dysphoria rather than to seek pleasure. At the same time, chronic stress impairs the prefrontal cortex, undermining decision-making and increasing impulsivity, which raises the likelihood of initiating and escalating substance use.
Social and clinical consequences
Stressors are not distributed equally. Communities experiencing poverty, discrimination, high exposure to violence, or geographic isolation face higher chronic stress burden, and epidemiological work links these contexts to elevated substance use disorder prevalence. Cultural stigma and limited access to trauma-informed care further compound risk and worsen outcomes. Clinically, individuals with chronic stress histories are more likely to relapse and respond poorly to standard treatments unless interventions address underlying stress and trauma. Treatments that combine behavioral therapies with stress-regulation strategies, and that consider social determinants of health, have a stronger evidence base according to public health guidance from the National Institute on Drug Abuse.
Understanding the pathways from chronic stress to addiction clarifies prevention and treatment priorities. Addressing upstream stressors through social policy, providing culturally sensitive mental health and trauma care, and targeting stress-related neurobiology in clinical interventions can reduce the transition from stress to substance dependence. Not everyone under chronic stress develops a substance use disorder, but for many people stress creates a biologically and socially mediated pathway that substantially increases risk.